Novartis Ag NVS
NYSE NVS
$151.25 -4.01 (-2.58%)
At close: Nov 19, 2026 · 4:00 PM EST

Novartis Ag (NVS) Capital Expenditures (2009 - 2026)

Updated

Novartis Ag (NVS) reported Capital Expenditures of $321 million for Q2 2026, down 3.0% from $331 million a year earlier.

Analysis

Novartis Ag (NVS) Capital Expenditures (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Novartis Ag's Capital Expenditures came in at -$988 million; for FY2025, it came in at $1.55 billion, up 13.3% from FY2024.

  • Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $1.37 billion in FY2024 (+28.9%), $1.06 billion in FY2023 (+15.7%), $916 million in FY2022 (-14.1%) and $1.07 billion in FY2021 (-16.4%).
  • Five-year quarterly Capital Expenditures spans a low of -$609 million in Q4 2025 and a high of $331 million in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$346 million (Q1 2026), -$609 million (Q4 2025) and -$354 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -39,045.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 3.18 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 1.36 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 301.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.04 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 237.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn 573.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 321.00 Mn
Mar 31, 2026 -346.00 Mn
Dec 31, 2025 -609.00 Mn
Sep 30, 2025 -354.00 Mn
Jun 30, 2025 331.00 Mn
Mar 31, 2025 -254.00 Mn
Dec 31, 2024 -558.00 Mn
Sep 30, 2024 -321.00 Mn
Jun 30, 2024 260.00 Mn
Mar 31, 2024 -227.00 Mn
Dec 31, 2023 -406.00 Mn
Sep 30, 2023 -261.00 Mn
Jun 30, 2023 225.00 Mn
Mar 31, 2023 -168.00 Mn
Dec 31, 2022 -306.00 Mn
Sep 30, 2022 -221.00 Mn
Jun 30, 2022 257.00 Mn
Mar 31, 2022 -257.00 Mn
Dec 31, 2021 -460.00 Mn
Sep 30, 2021 -351.00 Mn
API Access

Novartis Ag Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVS&period=max&api_key=YOUR_API_KEY